KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) EPS (Basic) (2019 - 2025)

Clover Health Investments (CLOV) has disclosed EPS (Basic) for 7 consecutive years, with -$0.1 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) fell 150.0% year-over-year to -$0.1, compared with a TTM value of -$0.17 through Dec 2025, down 70.0%, and an annual FY2025 reading of -$0.17, down 88.89% over the prior year.
  • EPS (Basic) was -$0.1 for Q4 2025 at Clover Health Investments, down from -$0.05 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.01 in Q2 2024 and bottomed at -$0.78 in Q2 2021.
  • Average EPS (Basic) over 5 years is -$0.15, with a median of -$0.1 recorded in 2025.
  • The sharpest move saw EPS (Basic) crashed 4000.0% in 2021, then skyrocketed 125.0% in 2024.
  • Year by year, EPS (Basic) stood at -$0.43 in 2021, then soared by 60.47% to -$0.17 in 2022, then grew by 17.65% to -$0.14 in 2023, then surged by 71.43% to -$0.04 in 2024, then tumbled by 150.0% to -$0.1 in 2025.
  • Business Quant data shows EPS (Basic) for CLOV at -$0.1 in Q4 2025, -$0.05 in Q3 2025, and -$0.02 in Q2 2025.